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INTRODUCTION
Postpartum haemorrhage (PPH) is a bleeding oc-
cured more than or equal with 500 cc after third
stage of labor.1 Postpartum haemorrhage is one of
major pregnancy complication which is happened
around 4-6% of vaginal delivery and it becomes
the main cause of maternal mortality and morbi-
dity. Each year, it causes 25-43% of maternal mor-
tality during delivery and it is related to 515,000-
600,000 cases of pregnancy death worldwide.1
According to survey conducted by Survey Demo-
grafi Kesehatan Indonesia (SDKI) in 2012, the
mortality rate in Indonesia was around 359 per
100,000 live births. This rate was increased from
228 per 100,000 live births in 2007.2
Uterine atony is the commonest cause of PPH
contributing around 70% of PPH cases. It can be
occurred right after delivery on both spontaneous
or operative vaginal delivery and abdominal
delivery.3 Moreover, uterine atony often becomes
the fastest killer for women in less than one hour
due to PPH. More than 90% cases of uterine atony
Abstract
Objective: To compare the effectiveness of rectal misoprostol ad-
ministration to the amount of blood loss in 4th stage of labor at high
risk pregnancy.
Method: We recruited all pregnant women with high risk criteria in-
cluding anemia, age  35 years old, or the number of pregnancies
 4. Women would deliver appropriate to standard procedure of
normal delivery. After that, we gave 400-mcg tablet of misoprostol
rectally in treatment group. To count the amount of blood loss
during 4th stage of labor, we put the underpad.
Result: The amount of blood loss in 4th stage of labor in the treat-
ment group was 201.1 (SD 80.3) ml less than the control group
(285.9 (SD 93.2) ml). The result showed that the administration of
400-mcg misoprostol tablet rectally immediately after the birth of
the placenta at high risk pregnancy impacted significantly to reduce
the amount of blood loss in 4th stage of labor (p<0.001). The inci-
dence of post-partum haemorrhage in the treatment group was
3.3% and 10% in control group. The drug side effects complained
were nausea (6.7%) and shivering (3.3%).
Conclusion: Administration of 400 mcg rectal misoprostol after de-
livering the placenta in high risk pregnancy has significant influence
to reduse the amount of blood less in fourth stage of labor.
[Indones J Obstet Gynecol 2016; 4-4: 187-189]
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Abstrak
Tujuan: Untuk membandingkan jumlah perdarahan kala IV persalin-
an yang diberikan misoprostol per rektal segera setelah lahirnyaplasenta pada kehamilan risiko tinggi.
Metode: Seluruh ibu hamil dengan salah satu kriteria risiko tinggiyang ditetapkan yaitu anemia, usia  35 tahun, atau kehamilan  4.
Ibu yang akan bersalin tersebut dilahirkan sesuai prosedur Asuhan
Persalinan Normal. Pada kelompok perlakuan, setelah lahirnya pla-senta, pasien segera diberikan tablet misoprostol 400 mcg per rektal.
Tetapi pada kelompok kontrol, tidak diberikan tablet misoprostol. Ke-mudian diletakkan alas bokong untuk menampung darah yang keluar
selama kala IV persalinan.
Hasil: Jumlah perdarahan pada kala IV persalinan kelompok per-
lakuan yaitu sebanyak 201,1 (SD 80,3) ml, lebih sedikit dibanding de-
ngan kelompok kontrol yaitu sebanyak 285,9 (93,2) ml. Dari hasil ujianalisis didapatkan bahwa pemberian tablet misoprostol 400 mcg per
rektal segera setelah lahirnya plasenta pada kehamilan risiko tinggimempunyai pengaruh yang signifikan untuk menurunkan jumlah per-
darahan kala IV persalinan (p<0,001). Jumlah perdarahan kala IV
500 ml pada kelompok perlakuan yaitu sebanyak 3,3% lebih sedikitdibandingkan dengan kelompok kontrol yaitu sebanyak 10%. Dite-
mukan efek samping obat pada sebagian kecil sampel berupa mual
(6,7%) dan menggigil (3,3%).
Kesimpulan: Pemberian 400 mcg misoprostol per rektal setelahpengeluaran plasenta pada kehamilan risiko tinggi dapat menurun-
kan jumlah perdarahan pada kala IV persalinan.
[Maj Obstet Ginekol Indones 2016; 4-4: 187-189]
Kata kunci: jumlah perdarahan, kala IV, misoprostol, rektal
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usually happen during the first 24 hours of
delivery. Therefore, supervision and prevention of
PPH are the main concern.4,5 In general, 88% of
PPH takes place during four hours after delivery
and anemia is the risk factor for massive PPH
among pregnant women in developing countries.6
Clinicians often use some types of prostaglandin
in fourth stage of labor to prevent PPH; however,
active management of third stage had been pro-
perly done. The most often prostaglandin agent
used to prevent PPH is misoprostol.7
Misoprostol as E1 prostaglandin is stable in high
temperature and it can be used orally, sublingually,
or even rectally. Misoprostol has been massively
used in obstetrics and gynecology cases to induce
the labor, management of abortion and PPH.8
Bamigboye, et al. reported that 400-mcg miso-
prostol given rectally is effective to prevent the
PPH.9
This study aims to determine the effect of 400-
mcg rectal misoprostol given after delivering the
placental to the amount of bleeding in fourth stage
of labor for high risk pregnancy.
METHODS
This study was a randomized controlled trial held
in delivery room of Dr. Wahidin Sudirohusodo
Hospital, Fatimah Mother and Child Hospital,
Pertiwi Mother and Child Hospital, Labuang Baji
Hospital in Makassar from November 2014 to
February 2015. The sample were taken through
consecutive random sampling. The number of
samples of each group were 30 subject. We
recruited the high risk pregnant women and
showed anemia through laboratory test (hemo-
globin level  9 g/dl), age  35 years old, or
grandemultipara ( 4 pregnancies).
Subjects in study group would immediately be
given the 400-mcg rectal misoprostol right after
delivering the placenta. Meanwhile, the control
group did not get anything. After that, we put the
underpad on the subjects’ bottom to measure the
amount of blood loss during fourth stage of labor.
Data taken from this study were written down and
further analyzed using SPSS. 
RESULTS
There were 60 subjects taken consisted of 30
subjects in each group of control and study.
Table 1 showed that blood loss volume in fourth
stage of labor fulfilling the high risk criteria. In
study group, the mean of blood loss was around
201.1 (SD 80.3) ml and 285.9 (SD 93.2) ml in
control group. Statistical analysis through
independent t test showed that there was a
significant difference in blood loss volume during
fourth stage of labor in high risk pregnancy women
(p<0.001).





Study group 201.1 80.3 84.8 <0.001
Control group 285.9 93.2
* Independent T-Test
Table 2. The Incidence of Postpartum Haemorrhage
The Amount of Blood Loss
in Stage 4 Labor Study GroupN (%) Control GroupN (%)
 500 ml 1 (3.3%) 3 (10%)
< 500 ml 29 (96.7%) 27 (90%)
Table 2 showed that there was only 3 of 30
subjects in control group and 1 of 30 subjects in
study group experiencing more than 500 ml blood
loss in fourth stage of labor. Table 3 depicted the
several side effects from rectal misoprostol
including nausea (6.7%) and shivering (3.3%).
Table 3. Side Effects from the Study
Side Effect Study Group
N (%) Control GroupN (%)
None 27 (90%) 30 (100%)
Nausea 2 (6.7%) 0 (0%)
Shivering 1 (3.3%) 0 (0%)
DISCUSSION
This study showed that the amount of blood loss
in fourth stage of labor for the whole subjects was
285.9 (SD 93.2) ml in control group and 201.1 (SD
80.3) ml in study group. The difference was
occurred due to the rectal misoprostol mechanism
of action in study group to reduce the amount of
blood loss. The statistical analysis through in-
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dep e n d e n t  t  t e s t  s h o w e d  t h e r e  w a s
significantly different between study and control
group of blood loss (p<0.001). A study by Laili
Chilmawati in Yogyakarta described that the
amount of blood loss in fourth stage of labor
among women who delivered vaginally was 102.13
(SD 67.34) ml in control group. This distinction
was happened due to the sample criteria of high
risk pregnant women. It made higher incidence of
blood loss compared with the study done in
Yogyakarta.10
The result of this study showed the significant
correlation between parity and the amount of
blood loss in fourth stage of labor among both
study (p=0.041) and control group (p=0.002). This
result revealed that blood loss in fourth stage of
labor was mostly influenced by parity as one of risk
factors instead of other risk factors. The result of
this study was in accordance with the other study;
whereas, the parity is claimed as the highest risk
of PPH among all others.11
The number of subjects with blood loss volume
more than 500 ml in fourth stage of labor were 3
(10%) and 1 (3.3%) in control and study group;
respectively. This result showed that 400-mcg
rectal misoprostol after delivering placenta could
reduce the incidence of PPH in high risk pregnancy.
Misoprostol is the recommendation agent to
prevent PPH which has officially been published by
International Confederation of Midwives (ICM) and
the International Federation of Gynecology and
Obstetrics (FIGO).8 On the other hand, this study
also found several side effects of rectal misoprostol
including nausea (6.7%) and shivering (3.3%). In
conclusion, the use of 400-mcg rectal misoprostol
is safe for the patients.
CONCLUSION
The use of 400-mcg rectal misoprostol right after
delivering the placenta in high risk pregnancy has
significant influence to reduce the amount of blood
loss in fourth stage of labor. Parity as a risk factor
is considered the strongest factors contributing the
amount of blood loss. The management of PPH
with rectal misoprostol after delivering placenta as
a prophylactic is recommended for high risk
pregnancy. In future, other studies should be
conducted to assess the impact of other high risk
factors toward blood loss volume in fourth stage
of labor.
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